EVIDENCE TABLES Table 1: Recommendations from United Kingdom (UK) and international referral guidelines for patients with suspected lung cancer

Size: px
Start display at page:

Download "EVIDENCE TABLES Table 1: Recommendations from United Kingdom (UK) and international referral guidelines for patients with suspected lung cancer"

Transcription

1 EVIDENCE TABLES Table 1: Recmmendatins frm United Kingdm (UK) and internatinal referral guidelines fr patients with suspected lung cancer Title, authrs, date and cuntry Lung cancer: the diagnsis and treatment f lung cancer - NICE clinical guideline UK Recmmendatins and gd practice pints Referral and indicatins fr chest radigraphy: 1. Urgent referral fr a chest X-ray shuld be ffered when a patient presents with: [2005] haemptysis, r any f the fllwing unexplained r persistent (that is, lasting mre than 3 weeks) symptms r signs: - cugh - chest/shulder pain - dyspnea - weight lss - chest signs - harseness - finger clubbing - features suggestive f metastasis frm a lung cancer (fr example, in brain, bne, liver r skin) - cervical/supraclavicular lymphadenpathy. 2. If a chest X-ray r chest cmputed tmgraphy (CT) scan suggests lung cancer (including pleural effusin and slwly reslving cnslidatin), patients shuld be ffered an urgent referral t a member f the lung cancer multidisciplinary team (MDT), usually a chest physician. [2005] Cmments Quality: 7 Recmmend: Yes [2005]: means that the evidence has nt been updated and reviewed since Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 1

2 authrs, date and cuntry Recmmendatins and gd practice pints 3. If the chest X-ray is nrmal but there is a high suspicin f lung cancer, patients shuld be ffered urgent referral t a member f the lung cancer MDT, usually the chest physician. [2005] 4. Patients shuld be ffered an urgent referral t a member f the lung cancer MDT, usually the chest physician, while awaiting the result f a chest X-ray, if any f the fllwing are present: persistent haemptysis in smkers/ex-smkers lder than 40 years signs f superir vena cava bstructin (swelling f the face/neck with fixed elevatin f jugular venus pressure) stridr. [2005] 5. Where a chest X-ray has been requested in primary r secndary care and is incidentally suggestive f lung cancer, a secnd cpy f the radilgist s reprt shuld be sent t a designated member f the lung cancer MDT, usually the chest physician. The MDT shuld have a mechanism in place t fllw up these reprts t enable the patient s GP t have a management plan in place. [2005] Cmments Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 2

3 authrs, date and cuntry Suspected cancer in primary care: guidelines fr investigatins, referral and reducing ethnic disparities - New Zealand Guidelines Grup New Zealand Recmmendatins and gd practice pints Urgent referral (within 2 weeks): 1. A persn shuld be referred urgently t a specialist if they have: Grade C persistent haemptysis and are smkers r ex-smkers aged 40 years r lder a chest x-ray suggestive f lung cancer (including pleural effusin and slwly reslving cnslidatin) 2. A persn shuld be referred urgently fr a chest x-ray if they have: Grade C r unexplained haemptysis any f the fllwing unexplained, persistent (lasting mre than 3 weeks r less than 3 weeks in peple with knwn risk factrs ) symptms and signs: - chest and/r shulder pain - shrtness f breath - weight lss/lss f appetite - abnrmal chest signs - harseness - finger clubbing - cervical and/r supraclavicular lymphadenpathy - cugh - features suggestive f metastasis frm a lung cancer (fr example in brain, bne, liver r skin). Current r ex-smkers, smking-related chrnic bstructive pulmnary disease, previus expsure t asbests, histry f cancer (especially head and neck cancer) Cmments Quality: 7 Recmmend: Yes, with mdificatins Grades f recmmendatin: All grades indicate the strength f the supprting evidence, rather than the imprtance f the recmmendatins. Grade C refers t recmmendatins supprted by internatinal expert pinin. Gd practice pints are develped, where n evidence is available, based n the pinin f the Guideline Develpment Team, r feedback frm cnsultatin within New Zealand. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 3

4 authrs, date and cuntry Recmmendatins and gd practice pints 3. A persn shuld be referred urgently t a specialist if they have a nrmal chest x-ray, but there is a high suspicin f lung cancer. Grade C This guideline further addressed a number f areas that were nt cvered in the NICE recmmendatins. This resulted in the develpment f fur gd practice pints (based n clinical expert pinin). Gd practice pints :cancer: referral/investigatin The smking status f all patients shuld be recrded and regularly updated in the practice ntes. After urgent referral fr chest x-ray, the chest x-ray shuld be cmpleted and reprted within ne week. A persn with risk factrs* fr lung cancer wh has cnslidatin n an initial chest x-ray shuld have a repeat chest x-ray within 6 weeks t cnfirm reslutin. Sputum cytlgy is nt recmmended fr the investigatin f lung cancer. *Current r ex-smkers, smking-related chrnic bstructive pulmnary disease, previus expsure t asbests, histry f cancer (especially head and neck cancer) Cmments Management f patients with lung cancer - SIGN clinical guideline Symptms and signs: 1. Patients shuld be referred urgently fr a chest X-ray if they have experienced unexplained r persistent haemptysis. Grade D Quality: 7 Recmmend: Yes Grades f recmmendatin: Grades indicate the strength f the Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 4

5 authrs, date and cuntry - UK Recmmendatins and gd practice pints 2. Patients shuld be referred fr a chest X-ray if any f the fllwing symptms persist fr mre than 3 weeks withut an bvius cause: Grade D cugh chest/shulder pain dyspnea weight lss chest signs harseness finger clubbing features suggestive f metastases frm lung cancer (fr example brain, bne, liver r skin) persistent cervical/supraclavicular lymphadenpathy. Referral t a respiratry physician: 3. Patients shuld be referred urgently t a chest physician if they have any f the fllwing: Grade D persistent haemptysis in smkers r ex-smkers ver 40 years f age a chest X-ray suggestive r suspicius f lung cancer (including pleural effusin and slwly reslving r recurrent cnslidatin) signs f superir vena caval bstructin (swelling f the face and r neck with fixed elevatin f jugular venus pressure) stridr (emergency referral). 4. Even with a nrmal chest X-ray, patients wh have experienced unexplained, nn-specific symptms, such as fatigue ptentially attributable t lung cancer, fr mre than 6 weeks shuld be Cmments supprting evidence, rather than the clinical imprtance f the recmmendatins. Grade D refers t refers t recmmendatins supprted by evidence frm level 3 r 4; r extraplated evidence frm studies rated as 2 +. Gd practice pints are recmmended best practice based n the clinical experience f the guideline develpment grup. Levels f evidence: 2 + : Well-cnducted case-cntrl r chrt studies with a lw risk f cnfunding r bias and a mderate prbability that the relatinship is causal 3: Nn-analytic studies, such as case reprts, case series 4: Expert pinin. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 5

6 authrs, date and cuntry Recmmendatins and gd practice pints referred urgently t a respiratry physician. Grade D Gd practice statement Patients referred t a respiratry physician shuld be seen prmptly, ideally within 2 weeks. Cmments Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 6

7 authrs, date and cuntry Referral guidelines fr suspected cancer - NICE clinical guideline UK Recmmendatins and gd practice pints General recmmendatins: 1. A patient wh presents with symptms suggestive f lung cancer shuld be referred t a team specialising in the management f lung cancer, depending n lcal arrangements. Grade D Specific recmmendatins: 2. An urgent referral fr a chest X-ray shuld be made when a patient presents with: Grade D haemptysis, r any f the fllwing unexplained persistent (that is, lasting mre than 3 weeks) symptms and signs: - chest and/r shulder pain - dyspnea - weight lss - chest signs - harseness - finger clubbing - cervical and/r supraclavicular lymphadenpathy - cugh with r withut any f the abve - features suggestive f metastasis frm a lung cancer (fr example, in brain, bne, liver r skin). A reprt shuld be made back t the referring primary healthcare prfessinal within 5 days f referral. 3. An urgent referral shuld be made fr either f the fllwing: Grade D persistent haemptysis in smkers r ex-smkers wh are aged 40 years and lder a chest X-ray suggestive f lung cancer (including pleural Cmments Quality: 7 Recmmend: Yes The referral timelines used in the guideline are as fllws: immediate: an acute admissin r referral ccurring within a few hurs, r even mre quickly if necessary urgent: the patient is seen within the natinal target fr urgent referrals (currently 2 weeks) nn-urgent: all ther referrals. Other definitins: Unexplained refers t a symptm(s) and/r sign(s) that has nt led t a diagnsis being made by the primary care prfessinal after initial assessment f the histry, examinatin and primary care investigatins (if any). Persistent refers t the cntinuatin f specified symptms and/r signs beynd a perid that wuld nrmally be assciated with self-limiting prblems. The precise perid will vary depending n the severity f symptms and assciated features, as assessed by the healthcare prfessinal. In many cases, the upper limit the prfessinal will permit symptms and/r signs t persist Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 7

8 authrs, date and cuntry Recmmendatins and gd practice pints effusin and slwly reslving cnslidatin). 4. Immediate referral shuld be cnsidered fr the fllwing: Grade D signs f superir vena caval bstructin (swelling f the face and/r neck with fixed elevatin f jugular venus pressure) stridr. Investigatins: 5. Unexplained changes in existing symptms in patients with underlying chrnic respiratry prblems shuld prmpt an urgent referral fr chest X-ray. Grade D 6. If the chest X-ray is nrmal, but there is a high suspicin f lung cancer, patients shuld be ffered an urgent referral. Grade D 7. In individuals with a histry f asbests expsure and recent nset f chest pain, shrtness f breath r unexplained systemic symptms, lung cancer shuld be cnsidered and a chest X-ray arranged. If this indicates a pleural effusin, pleural mass r any suspicius lung pathlgy, an urgent referral shuld be made. Grade C Cmments befre initiating referral will be 4 6 weeks. Grades f recmmendatin: Grade C is directly based n: categry III evidence, r extraplated recmmendatin frm categry I r II evidence Grade D is directly based n: categry IV evidence, r extraplated recmmendatin frm categry I, II, r III evidence. Levels f evidence: Ia: Evidence frm systematic review r meta-analysis f randmised cntrlled trials Ib: Evidence frm at least ne randmised cntrlled trial IIa: Evidence frm at least ne welldesigned cntrlled study withut randmisatin IIb: Evidence frm at least ne welldesigned quasi-experimental study, such as a chrt study III: Evidence frm well-designed nnexperimental descriptive studies, casecntrl studies, r case series IV: Evidence frm expert cmmittee reprts, pinins and/r clinical experience f respected authrities. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 8

9 authrs, date and cuntry Clinical Practice Guidelines fr the Preventin, Diagnsis and Management f Lung Cancer - Natinal Health and Medical Research Cuncil Australia Lung cancer. Practice rganizatin - Alberts WM, Bepler G, Hazeltn T, Ruckdeschel JC, Williams JH Jr US Recmmendatins and gd practice pints All individuals with suspected lung cancer shuld be referred t a specialist with expertise in the management f lung disease fr an pinin. Level IV evidence Referral pattern 1. All patients with knwn r suspected lung cancer shuld be referred t a multidisciplinary team f physicians r a physician with experience in the management f lung cancer. (Quality f evidence: pr; net benefit: substantial; strength f recmmendatin: C) 2. Fr patients in whm tissue diagnsis r staging remains incmplete, referral shuld be t a specialist with expertise in these areas. When cmpleted, the chice f referral may vary with the interventins(s) prpsed. (Quality f evidence: pr; net benefit: mderate; strength f recmmendatin: C) Cmments Quality: 7 Recmmend: Yes, with mdificatins Levels f evidence: Level IV refers t evidence btained frm case series, either pst-test r pre-test and pst-test. Quality: 7 Recmmend: Yes, with mdificatins Grades f recmmendatin: Grade C recmmendatin indicates that there was cnsensus amng the panel t recmmend [the service] but that the evidence that [the service] is effective is lacking, f pr quality, r cnflicting, r the balance f benefits and harm cannt be reliably determined frm available evidence. Definitin f net benefit types: The levels f net benefit are based n clinical assessment. Estimated net benefit may be dwngraded based n uncertainty in estimates f benefits and harms. Substantial benefit: Benefit greatly utweighs harm. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 9

10 authrs, date and cuntry Recmmendatins and gd practice pints Cmments Mderate benefit: Benefit utweighs harm. Small/weak benefit: Benefit utweighs harm t a minimally clinically imprtant degree. Nne/negative benefit: Harms equal r utweigh benefit, less than clinically imprtant. Referral Guidelines fr Suspected Cancer - UK Department f Health UK Guidelines fr urgent referral Nte: In mst cases where lung cancer is suspected it is apprpriate t arrange an urgent chest x-ray befre urgent referral t a chest physician. 1. Urgent referral fr a chest x-ray haemptysis unexplained r persistent (mre than 3 weeks) - cugh - chest/shulder pain - dyspnea - weight lss - chest signs - harseness - finger clubbing - features suggestive f metastasis frm a lung cancer (fr example brain, bne, liver r skin) - persistent cervical/supraclavicular lymphadenpathy. Quality: 7 Recmmend: Yes Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 10

11 authrs, date and cuntry Recmmendatins and gd practice pints 2. Urgent referral t a chest physician Any f the fllwing: chest x-ray suggestive/suspicius f lung cancer (including pleural effusin and slwly reslving cnslidatin). persistent haemptysis in smkers/ex-smkers ver 40 years f age. signs f superir vena caval bstructin (swelling f face/neck with fixed elevatin f jugular venus pressure). stridr (cnsider emergency referral). Cmments Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 11

12 Table 2: Recmmendatins frm UK and internatinal referral guidelines fr patients with suspected breast cancer Title, authrs, date and cuntry Healthcare guideline: diagnsis f breast disease - Institute fr Clinical Systems Imprvement USA Recmmendatins and gd practice pints Clinical highlights: 1. Patients with a bldy r clear discharge shuld be referred t a radilgist and/r surgen fr further evaluatin. 2. A persistent mass with negative imaging des nt rule ut malignancy and requires a referral t a surgen. Cmments Quality: 6 Recmmend: Yes, with mdificatins Anntatins: The wrk grup utilised infrmatin frm current and ptimal practices t develp r revise clinical patient pathways and algrithms, and t draft anntatins. Suspected cancer in primary care: guidelines fr investigatins, referral and reducing ethnic disparities - New Zealand Guidelines Grup New Zealand Recmmendatins fr urgent referral (within 2 weeks): 1. A wman with a palpable hard, fixed r tethered breast lump shuld be referred urgently t a specialist.* Grade C 2. A persn presenting with unilateral eczematus skin r nipple change that des nt respnd t tpical treatment, r with nipple distrtin f recent nset, shuld be referred urgently t a specialist.* Grade C 3. A persn presenting with spntaneus unilateral bldy nipple discharge shuld be referred urgently t a specialist.* Grade C Recmmendatins fr referral/investigatin: 1. A palpable breast lump in a wman shuld be investigated. Grade C 2. A wman with an abscess r mastitis which des nt settle after ne curse f antibitics shuld be referred t a specialist. Grade C Quality: 7 Recmmend: Yes, with mdificatins Grades f recmmendatin: Grades indicate the strength f the supprting evidence, rather than the imprtance f the recmmendatins. Grade C refers t recmmendatins supprted by internatinal expert pinins Gd practice pints are develped, where n evidence is available, based n the pinin f the Guideline Develpment Team, r feedback frm cnsultatin within New Zealand. *Recmmendatin cnsistent with: Referral guidelines fr suspected cancer. NICE clinical guideline Recmmendatin cnsistent with: Scttish Intercllegiate Guidelines Netwrk. Management f breast cancer in wmen. Natinal clinical guideline N. 84. Edinburgh: SIGN; Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 12

13 authrs, date and cuntry Familial breast cancer: The classificatin and care f wmen at risk f familial breast cancer in primary, secndary and tertiary care Recmmendatins and gd practice pints 3. A wman ver 40 years f age with a breast abscess that has settled shuld be referred fr mammgraphy. Grade C 4. Persistent, unilateral, unexplained breast pain in a pstmenpausal wman shuld be investigated. Grade C 5. Fr a persn presenting slely with breast pain, with n palpable abnrmality, referral t a specialist may be cnsidered in the event f failure f initial treatment and/r unexplained persistent symptms. Initial mammgraphy is nt recmmended.* Grade C Gd practice pints fr referral/investigatin 1. An adult man with a unilateral, firm subarelar mass shuld be referred t a specialist.* 2. Fr a persn presenting with symptms and/r signs suggestive f breast cancer, investigatin may be instigated by the practitiner, but shuld nt delay referral t a specialist. 3. A wman under 30 years f age presenting with generalised lumpiness in the breast tissue, where a fcal area f cncern, unchanged fllwing a menstrual perid, is identified, shuld be referred t a specialist. If a wman has a family histry f premature breast cancer an earlier referral fr investigatin shuld be cnsidered. When a wman presents with breast symptms r has cncerns abut relatives with breast cancer, a first- and secnd-degree family histry shuld be taken in primary care t assess risk, because this allws apprpriate classificatin and care. Cmments Quality: 7 Recmmend: Yes Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 13

14 authrs, date and cuntry - NICE clinical guideline UK Recmmendatins and gd practice pints Referral frm primary care: 1. Wmen wh meet the fllwing criteria shuld be ffered referral t secndary care: r r ne first-degree female relative diagnsed with breast cancer at yunger than age 40 years, r ne first-degree male relative diagnsed with breast cancer at any age, r ne first-degree relative with bilateral breast cancer where the first primary was diagnsed at yunger than age 50 years tw first-degree relatives, r ne first-degree and ne secnddegree relative, diagnsed with breast cancer at any age, r ne first-degree r secnd-degree relative diagnsed with breast cancer at any age and ne first-degree r secnddegree relative diagnsed with varian cancer at any age (ne f these shuld be a first-degree relative) three first-degree r secnd-degree relatives diagnsed with breast cancer at any age. Cmments Referral guidelines fr suspected cancer - NICE clinical guideline UK 2. Direct referral t a specialist genetics service shuld take place where a high-risk predispsing gene mutatin has been identified (fr example, BRCA1, BRCA2 r TP53). General recmmendatins: 1. A patient wh presents with symptms suggestive f breast cancer shuld be referred t a team specialising in the management f breast cancer. Grade D 2. In mst cases, the definitive diagnsis will nt be knwn at the time f referral, and many patients wh are referred will be fund nt t have cancer. Hwever, primary healthcare Quality: 7 Recmmend: Yes Grades f recmmendatin: Grade C is directly based n: categry III evidence, r extraplated recmmendatin frm categry I Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 14

15 authrs, date and cuntry Recmmendatins and gd practice pints prfessinals shuld cnvey ptimism abut the effectiveness f treatment and survival because a patient being referred with a breast lump will be naturally cncerned. Grade C 3. Peple f all ages wh suspect they have breast cancer may have particular infrmatin and supprt needs. The primary healthcare prfessinal shuld discuss these needs with the patient and respnd sensitively t them. Grade D 4. Primary healthcare prfessinals shuld encurage all patients, including wmen ver 50 years ld, t be breast aware in rder t minimise delay in the presentatin f symptms. Grade D Specific recmmendatins: 1. A wman s first suspicin that she may have breast cancer is ften when she finds a lump in her breast. The primary healthcare prfessinal shuld examine the lump with the patient s cnsent. The features f a lump that shuld make the primary healthcare prfessinal strngly suspect cancer are a discrete, hard lump with fixatin, with r withut skin tethering. In patients presenting in this way an urgent referral shuld be made, irrespective f age. Grade C 2. In a wman aged 30 years and lder with a discrete lump that persists after her next perid, r presents after menpause, an urgent referral shuld be made. Grade C 3. Breast cancer in wmen aged yunger than 30 years is rare, but des ccur. Benign lumps (fr example, fibradenma) are cmmn, hwever, and a plicy f referring these wmen urgently wuld nt be apprpriate; instead, nn-urgent referral shuld be cnsidered. Hwever, an urgent referral shuld be Cmments r II evidence Delete space fr cnsistency with thers Grade D is directly based n: categry IV evidence, r extraplated recmmendatin frm categry I, II, r III evidence Delete space Grade B (DS) is directly based n categry II evidence (evidence frm level 2 studies, r systematic reviews f level 2 studies) DS refers t diagnstic studies. Levels f evidence: Ia: Evidence frm systematic review r metaanalysis f randmised cntrlled trials Ib: Evidence frm at least ne randmised cntrlled trial IIa: Evidence frm at least ne well-designed cntrlled study withut randmisatin IIb: Evidence frm at least ne well-designed quasi-experimental study, such as a chrt study III: Evidence frm well-designed nnexperimental descriptive studies, case-cntrl studies, r case series IV: Evidence frm expert cmmittee reprts, pinins and/r clinical experience f respected authrities. Level-2 studies are studies that have nly ne f the fllwing: narrw ppulatin (the sample des nt Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 15

16 authrs, date and cuntry Recmmendatins and gd practice pints made in wmen aged yunger than 30 years: with a lump that enlarges, Grade C r with a lump that has ther features assciated with cancer (fixed and hard), Grade C r in whm there are ther reasns fr cncern such as family histry. Grade D 4. The patient s histry shuld always be taken int accunt. Fr example, it may be apprpriate, in discussin with a specialist, t agree referral within a few days in patients reprting a lump r ther symptm that has been present fr several mnths. Grade D 5. In a patient wh has previusly had histlgically cnfirmed breast cancer, wh presents with a further lump r suspicius symptms, an urgent referral shuld be made, irrespective f age. Grade C 6. In patients presenting with unilateral eczematus skin r nipple change that des nt respnd t tpical treatment, r with nipple distrtin f recent nset, an urgent referral shuld be made. Grade C 7. In patients presenting with spntaneus unilateral bldy nipple discharge, an urgent referral shuld be made. Grade C 8. Breast cancer in men is rare and is particularly rare in men under 50 years f age. Hwever, in a man aged 50 years and lder with a unilateral, firm subarelar mass with r withut nipple distrtin r assciated skin changes, an urgent referral shuld be made. Grade C Cmments reflect the ppulatin t whm the test wuld apply) use a pr reference standard (defined as that where a test is included in the reference, r where the testing affects the reference ) the cmparisn between the test and reference standard is nt blind are case-cntrl studies. Investigatins: Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 16

17 authrs, date and cuntry Recmmendatins and gd practice pints 9. In patients presenting with symptms and/r signs suggestive f breast cancer, investigatin prir t referral is nt recmmended. Grade D 10. In patients presenting slely with breast pain, with n palpable abnrmality, there is n evidence t supprt the use f mammgraphy as a discriminatry investigatin fr breast cancer. Therefre, its use in this grup f patients is nt recmmended. Nn-urgent referral may be cnsidered in the event f failure f initial treatment and/r unexplained persistent symptms. Grade B (DS) Cmments Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 17

18 authrs, date and cuntry Management f breast cancer in wmen - SIGN clinical guideline UK Clinical practice guidelines fr the management and supprt f yunger wmen with breast cancer - Natinal Health and Medical research Cuncil Australia Recmmendatins and gd practice pints Triggers fr prmpt referral t a breast clinic: Referral frm primary t specialist care shuld be made in accrdance with the Scttish Cancer Grup referral guideline (see Appendix 1). Yunger age has been assciated with physician delay in referral fr investigatin f breast symptms. Fr this reasn, yung wmen presenting with breast symptms shuld be evaluated by means f the triple test apprach t exclude r establish a diagnsis f cancer. Level III-2 Cmments Quality: 7 Recmmend: Yes Gd practice pints are recmmended best practice based n the clinical experience f the guideline develpment grup. Quality: 6 Recmmend: Yes, with mdificatins Level III-2 refers t evidence which is btained frm cmparative studies with cncurrent cntrls and allcatin nt randmised (chrt studies). Clinical practice guidelines fr the management f early breast cancer: Secnd editin - Natinal Health and Medical research Cuncil Australia Key pint (nt recmmendatin): When rganising referral fr wmen with breast cancer, GPs shuld cnsider bth the preferences f the patient and the fact that patient utcmes are better if treated by clinicians wh are part f a multidisciplinary team. Quality: 7 Recmmend: Yes, with mdificatins Guidance n cancer service: imprving utcmes in breast cancer Cnditins that require urgent referral (within 2 weeks): 1. Patients aged 30 r ver (the precise age criterin t be agreed by each netwrk) with a discrete lump in the breast. Quality: 7 Recmmend: Yes Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 18

19 authrs, date and cuntry - NICE UK Recmmendatins and gd practice pints 2. Patients with breast signs r symptms which are highly suggestive f cancer. These include: ulceratin skin ndule skin distrtin nipple eczema recent nipple retractin r distrtin (< 3 mnths) unilateral nipple discharge which stains clthes. Cnditins that require referral, nt necessarily urgent: 1. Breast lumps in the fllwing patients, r f the fllwing types: discrete lump in a yunger wman (age < 30 years) asymmetrical ndularity that persists at review after menstruatin abscess persistently refilling r recurrent cyst. 2. Intractable pain which des nt respnd t simple measures such as wearing a well-fitting bra and using ver-the-cunter analgesics such as paracetaml. Cmments 3. Nipple discharge: bilateral discharge sufficient t stain clthes in patients aged < 50 years bldstained discharge in patients aged < 50 years (urgent referral required if discharge is unilateral) any nipple discharge in patients ver 50 years f age. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 19

20 authrs, date and cuntry Referral guidelines fr suspected cancer - UK Department f Health UK Recmmendatins and gd practice pints Guidelines fr urgent referral: 1. Patients with a discrete lump in the apprpriate age grup (fr example age > 30). 2. Signs which are highly suggestive f cancer such as: ulceratin skin ndule skin distrtin nipple eczema recent nipple retractin r distrtin (< 3 mnths). Cnditins that require referral but nt necessarily urgently: 1. Lump discrete lump in a yunger wman (fr example age < 30 years) asymmetrical ndularity that persists at review after menstruatin abscess persistently refilling r recurrent cyst. 2. Pain intractable pain nt respnding t reassurance, simple measures such as wearing a well supprting bra and cmmn drugs. 3. Nipple age < 50 with bilateral discharge sufficient t stain clthes. Cmments Quality: 7 Recmmend: Yes Nte: The guidelines fr urgent referral f patients with suspected breast cancer in this dcument are based n recmmendatins set ut in Guidelines fr Referral f Patients with Breast Prblems secnd editin 1999 prepared by Jan Austker and Rbert Mansel under the auspices f the NHS Breast Screening Prgramme and the Cancer Research Campaign. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 20

21 authrs, date and cuntry 4. Discharge Recmmendatins and gd practice pints Cmments age < 50 with bldstained discharge age > 50 with any nipple discharge. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 21

22 Table 3: Recmmendatins frm UK and internatinal referral guidelines fr patients with suspected lwer gastrintestinal cancer Title, authrs, date and cuntry Diagnsis and management f clrectal cancer - SIGN clinical guideline UK Recmmendatins and gd practice pints Recmmendatins fr primary care and referral: 1. Patients ver the age f 40 wh present with new nset, persistent r recurrent rectal bleeding shuld be referred fr investigatin. Grade B 2. Review f the patient by a reginal clinical genetics service is recmmended fr accurate risk assessment if family histry f clrectal cancer is the principal indicatin fr referral fr investigatin. Grade C 3. General practitiners shuld perfrm an abdminal and rectal examinatin n all patients with symptms indicative f clrectal cancer. A psitive finding shuld expedite referral, but a negative rectal examinatin shuld nt rule ut the need t refer. Grade B 4. All symptmatic patients shuld have a full bld cunt. In cases f anaemia the presence f irn deficiency shuld be determined. Grade B Cmments Quality: 7 Recmmend: Yes Grades f recmmendatin: Grade B refers t a bdy f evidence including studies rated as 2 ++, directly applicable t the target ppulatin, and demnstrating verall cnsistency f results; r extraplated evidence frm studies rated as 1 ++ r 1 +. Grade C refers t a bdy f evidence including studies rated as 2 +, directly applicable t the target ppulatin and demnstrating verall cnsistency f results; r extraplated evidence frm studies rated as Levels f evidence: 1 ++ : High quality meta-analyses, systematic reviews f RCTs, r RCTs with a very lw risk f bias 1 + : Well-cnducted meta-analyses, systematic reviews, r RCTs with a lw risk f bias 2 ++ : High quality systematic reviews f case-cntrl r chrt studies OR high quality case-cntrl r chrt studies with a very lw risk f cnfunding r bias and a high prbability that the relatinship is causal. 2 + : Well-cnducted case-cntrl r chrt studies Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 22

23 authrs, date and cuntry Guidelines fr clrectal cancer screening and surveillance in mderate and high risk grups (update frm 2002) - The British Sciety f Gastrenterlgy (BSG) and the Assciatin f Clprctlgy fr Great Britain and Ireland (ACPGBI) UK Recmmendatins and gd practice pints Guidance n large bwel surveillance fr individuals with a family histry indicating a mderate risk: 1. Referrals n the basis f family histry are best crdinated thrugh centres with a specialist interest, such as reginal genetics services r medical/surgical gastrenterlgy centres. Such centralisatin enables audit f family histry ascertainment, assigned level f risk, cllectin f utcme data and research. Grade C Cmments with a lw risk f cnfunding r bias and a mderate prbability that the relatinship is causal. Quality: 5 Recmmend: Yes, with mdificatins The strength f each recmmendatin is dependent upn the categry f the evidence supprting it. Grade C is based n evidence btained frm expert cmmittee reprts r pinins r clinical experiences f respected authrities. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 23

24 authrs, date and cuntry Suspected cancer in primary care: guidelines fr investigatins, referral and reducing ethnic disparities - New Zealand Guidelines Grup New Zealand Recmmendatins and gd practice pints Recmmendatins fr urgent referral (within 2 weeks): 1. A persn aged 40 years and lder reprting rectal bleeding with a change f bwel habit twards lser stls and/r increased stl frequency persisting fr 6 weeks r mre shuld be referred urgently t a specialist.* Grade C 2. A persn aged 60 years and lder with rectal bleeding persisting fr 6 weeks r mre withut a change in bwel habit and withut anal symptms shuld be referred urgently t a specialist.* Grade C 3. A persn aged 60 years and lder with a change in bwel habit t lser stls and/r mre frequent stls persisting fr 6 weeks r mre withut rectal bleeding shuld be referred urgently t a specialist.* Grade C 4. A persn presenting with a palpable rectal mass (intraluminal and nt pelvic), shuld be referred urgently t a specialist, irrespective f age. Nte that a pelvic mass utside the bwel shuld be referred urgently t a urlgist r gynaeclgist.* Grade C 5. A man f any age with unexplained irn deficiency anaemia and a haemglbin f 110 g/l r belw, shuld be referred urgently t a specialist.* Grade C 6. A nn-menstruating wman with unexplained irn deficiency anaemia and a haemglbin f 100 g/l r belw, shuld be referred urgently t a specialist.* Grade C Cmments Quality: 7 Recmmend: Yes, with mdificatins Grades f recmmendatin: Grades indicate the strength f the supprting evidence, rather than the imprtance f the recmmendatins. Grade C refers t recmmendatins supprted by internatinal expert pinins. Gd practice pints are develped, where n evidence is available, based n the pinin f the Guideline Develpment Team, r feedback frm cnsultatin within New Zealand. *Recmmendatin cnsistent with: Referral guidelines fr suspected cancer. NICE clinical guideline **Unexplained irn deficiency anaemia means unrelated t ther surces f bld lss, fr example, nn-steridal anti-inflammatry drug treatment r bld dyscrasia. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 24

25 authrs, date and cuntry Recmmendatins and gd practice pints Gd practice pints fr urgent referral (within 2 weeks): 1. A persn presenting with a right-sided abdminal mass, shuld be referred urgently fr a surgical pinin. 2. A menstruating wman with unexplained irn deficiency anaemia** and a haemglbin f 100 g/l r belw, shuld be referred urgently t a specialist. Recmmendatins fr referral/investigatin: 1. Fr a persn with equivcal symptms, a cmplete bld cunt may help in identifying the pssibility f clrectal cancer by demnstrating irn deficiency anaemia. This shuld determine if a referral is needed and whether the persn shuld be urgently referred t a specialist.* Grade C 2. Fr a persn where the decisin t refer t a specialist has been made, a cmplete bld cunt may be cnsidered t assist specialist assessment in the utpatient clinic.* Grade C 3. Fr a persn where the decisin t refer t a specialist has been made, n examinatins r investigatins ther than an abdminal and rectal examinatin, and a cmplete bld cunt shuld be undertaken as this may delay referral.* Grade C Gd practice pints fr referral/investigatin: 1. A persn at lw risk f clrectal cancer with a significant symptm (rectal bleeding r a change in bwel habit) and a nrmal rectal examinatin, n anaemia and n abdminal mass, shuld be managed by a strategy f Cmments Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 25

26 authrs, date and cuntry Recmmendatins and gd practice pints treat, watch and review in 3 mnths. 2. In a persn presenting with a left-sided abdminal mass, faecal lading shuld first be excluded as the cause. A referral shuld then be made fr a surgical pinin. 3. Faecal ccult bld and carcingenic embrynic antigen testing are f little value in a persn with symptms suggestive f clrectal cancer and shuld nt be used. 4. A persn with any unexplained gastrintestinal symptms and knwn high-risk factrs, fr example, familial adenmatus plypsis, hereditary nnplypsis clrectal cancer, ther familial clrectal syndrmes r a past histry f lwer gastrintestinal cancer shuld be referred t a specialist. Cmments Referral guidelines fr suspected cancer - NICE clinical guideline UK General recmmendatins: 1. A patient wh presents with symptms suggestive f clrectal r anal cancer shuld be referred t a team specialising in the management f lwer gastrintestinal cancer, depending n lcal arrangements. Grade D Specific recmmendatins: 1. In patients aged 40 years and lder, reprting rectal bleeding with a change f bwel habit twards lser stls and/r increased stl frequency persisting fr 6 weeks r mre, an urgent referral shuld be made. Grade C 2. In patients aged 60 years and lder, with rectal bleeding persisting fr 6 weeks r mre withut a change in bwel Quality: 7 Recmmend: Yes Grades f recmmendatin: Grade C is directly based n: categry III evidence, r extraplated recmmendatin frm categry I r II evidence. Grade D is directly based n: categry IV evidence, r extraplated recmmendatin frm categry I, II, r III evidence. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 26

27 authrs, date and cuntry Recmmendatins and gd practice pints habit and withut anal symptms, an urgent referral shuld be made. Grade C 3. In patients aged 60 years and lder, with a change in bwel habit t lser stls and/r mre frequent stls persisting fr 6 weeks r mre withut rectal bleeding, an urgent referral shuld be made. Grade C 4. In patients presenting with a right lwer abdminal mass cnsistent with invlvement f the large bwel, an urgent referral shuld be made, irrespective f age. Grade C 5. In patients presenting with a palpable rectal mass (intraluminal and nt pelvic), an urgent referral shuld be made, irrespective f age. (A pelvic mass utside the bwel wuld warrant an urgent referral t a urlgist r gynaeclgist.) Grade C 6. In men f any age with unexplained irn deficiency anaemia and a haemglbin f 11 g/100 ml r belw, an urgent referral shuld be made. Grade C 7. In nn-menstruating wmen with unexplained irn deficiency anaemia and a haemglbin f 10 g/100 ml r belw, an urgent referral shuld be made. Grade C Recmmendatins fr patients with risk factrs: 1. In patients with ulcerative clitis r a histry f ulcerative clitis, a plan fr fllw up shuld be agreed with a specialist and ffered t the patient as a nrmal prcedure in an effrt t detect clrectal cancer in this high-risk grup. Grade C Cmments Levels f evidence: Ia: Evidence frm systematic review r metaanalysis f randmised cntrlled trials Ib: Evidence frm at least ne randmised cntrlled trial IIa: Evidence frm at least ne well-designed cntrlled study withut randmisatin IIb: Evidence frm at least ne well-designed quasi-experimental study, such as a chrt study III: Evidence frm well-designed nn-experimental descriptive studies, case-cntrl studies, r case series IV: Evidence frm expert cmmittee reprts, pinins and/r clinical experience f respected authrities. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 27

28 authrs, date and cuntry Recmmendatins and gd practice pints Cmments 2. There is insufficient evidence t suggest that a psitive family histry f clrectal cancer can be used as a criterin t assist in the decisin abut referral f a symptmatic patient. Grade C Clinical Practice Guidelines fr the preventin, early detectin and management f clrectal cancer - Natinal Health and Medical Research Cuncil Australia Investigatin: 1. In symptmatic patients aged ver 40 years, referral t a specialist shuld be cnsidered and cnsideratin f full examinatin f the cln with clnscpy is recmmended. Level III-3; Equivcal Quality: 7 Recmmend: Yes, with mdificatins Levels f evidence: Level III-3 refers t evidence btained frm cmparative studies with histrical cntrl, tw r mre single arm studies, r interrupted time series withut a parallel cntrl grup. Grades f recmmendatin: Strength f evidence was determined by the expert advisry panel. Equivcal refers t situatins where there is lack f higher levels f evidence (such as III-3 r IV) OR equivcal level I r II evidence fr and against clinical questin n recmmendatin fr r against, as evidence is incnclusive recmmend further research. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 28

29 authrs, date and cuntry Guidance n cancer services: imprving utcmes in clrectal cancers - NICE UK Recmmendatins and gd practice pints Actin shuld be taken t imprve recgnitin f ptential symptms f clrectal cancer in primary care and in the cmmunity. Efficient systems shuld be set up t ensure that patients wh may have clrectal cancer are rapidly referred fr endscpy. Criteria fr urgent referral: Age threshld Cmments Quality: 7 Recmmend: Yes rectal bleeding WITH a change in bwel habit t lser stls and/r increased frequency f defecatin persistent fr 6 weeks a definite palpable right-sided abdminal mass a definite palpable rectal (nt pelvic) mass rectal bleeding persistently WITHOUT anal symptms* change f bwel habit t lser stls and/r increased frequency f defecatin, WITHOUT rectal bleeding and persistent fr 6 weeks irn deficiency anaemia WITHOUT an bvius cause (Hb < 11 g/dl in men r < 10 g/dl in pstmenpausal wmen). All ages All ages All ages Over 60 years Over 60 years N age criterin Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 29

30 authrs, date and cuntry Recmmendatins and gd practice pints * Anal symptms include sreness, discmfrt, itching, lumps and prlapse as well as pain. Age 60 years is cnsidered t be the maximum age threshld. Lcal Cancer Netwrks may elect t set a lwer age threshld (such as 55 years r 50 years). Additinal ntes 1. Symptms ther than thse in the list abve, which shuld als prmpt referral fr endscpy, include faecal incntinence and passing mucus via the rectum. 2. Patients with irn-deficiency anaemia (apart frm menstruating wmen) shuld be referred fr clnscpy 3. The threshld fr referral fr investigatin shuld be reduced if ther members f the patient s family have had a diagnsis f clrectal cancer. 4. GPs shuld nt refer patients with suspected clrectal cancer t a specific clinician (as ppsed t a diagnstic clinic) wh is nt a cre member f a clrectal cancer multidisciplinary team Patients with nn-specific symptms: 1. The mst cmmn nn-specific symptms f clrectal cancer fr example, tiredness are due t irndeficiency anaemia caused by undetected bld lss, particularly in lder men r pst-menpausal wmen; patients with bwel plyps r cancer may have n ther symptms. Trusts shuld agree specific lcal guidelines which ensure that such patients are referred prmptly t the endscpy service. Cmments Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 30

31 authrs, date and cuntry Referral Guidelines fr Suspected Cancer - UK Department f Health UK Recmmendatins and gd practice pints 2. Peple with tw first-degree relatives with clrectal cancer, r ne first-degree relative whse clrectal cancer is diagnsed befre the age f 45, have a lifetime risk f death frm clrectal cancer f 1 in 6, r 1 in 10, respectively. The British Sciety f Gastrenterlgy (BSG) and the Assciatin f Clprctlgy fr Great Britain and Ireland (ACPGBI) guidelines suggest that peple wh meet these criteria shuld be referred fr clnscpy at years f age, r as sn thereafter as the risk is recgnised. Guidelines fr urgent referral: It is recmmended that the fllwing symptm and sign cmbinatins when ccurring fr the first time shuld be used t identify patients fr urgent referral under the 2 week standard: Age threshld Cmments Quality: 6 Recmmend: Yes rectal bleeding WITH a change in bwel habit t lser stls and/r increased frequency f defecatin persistent fr 6 weeks a definite palpable right-sided abdminal mass a definite palpable rectal (nt pelvic) mass rectal bleeding persistently WITHOUT anal symptms* All ages All ages All ages Over 60 years Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 31

32 authrs, date and cuntry Recmmendatins and gd practice pints change f bwel habit t lser stls and/r increased frequency f defecatin, WITHOUT rectal bleeding and persistent fr 6 weeks. Over 60 years Cmments Irn deficiency anaemia WITHOUT an bvius cause (Hb < 11 g/dl in men r < 10 g/dl in pstmenpausal wmen). Nte: Patients with the fllwing symptms and n abdminal r rectal mass, are at very lw risk f cancer: rectal bleeding with anal symptms* change in bwel habit t decreased frequency f defecatin and harder stls abdminal pain withut clear evidence f intestinal bstructin. * Anal symptms include sreness, discmfrt, itching, lumps and prlapse as well as pain. Age 60 years is cnsidered t be the maximum age threshld. Lcal Cancer Netwrks may elect t set a lwer age threshld (such as 55 years r 50 years). Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 32

33 Table 4: Recmmendatins frm UK and internatinal referral guidelines fr patients with suspected esphaggastric, hepatbiliary and pancreatic cancers Title, authrs, date and cuntry Recmmendatins and gd practice pints Cmments Referral guidelines fr suspected cancer - NICE clinical guideline UK General recmmendatins: A patient wh presents with symptms suggestive f upper gastrintestinal cancer shuld be referred t a team specialising in the management f upper gastrintestinal cancer, depending n lcal arrangements. Grade D Specific recmmendatins: An urgent referral fr endscpy r t a specialist with expertise in upper gastrintestinal cancer shuld be made fr patients f any age with dyspepsia wh present with any f the fllwing: chrnic gastrintestinal bleeding dysphagia prgressive unintentinal weight lss persistent vmiting irn deficiency anaemia epigastric mass suspicius barium meal result. Grade C In patients aged 55 years and lder with unexplained and persistent recent-nset dyspepsia alne, an urgent referral fr endscpy shuld be made. Grade D In patients aged less than 55 years, endscpic investigatin f dyspepsia is nt necessary in the absence f alarm symptms. Grade D In patients presenting with dysphagia (interference with the swallwing mechanism that ccurs within 5 secnds Quality: 7 Recmmend: Yes Dyspepsia in unselected patients in primary care is defined bradly t include patients with recurrent epigastric pain, heartburn r acid regurgitatin, with r withut blating, nausea r vmiting. Unexplained is defined as a symptm(s) and/r sign(s) that has nt led t a diagnsis being made by the primary care prfessinal after initial assessment f the histry, examinatin and primary care investigatins (if any). In the cntext f this recmmendatin, the primary care prfessinal shuld cnfirm that the dyspepsia is new rather than a recurrent episde and exclude cmmn precipitants f dyspepsia such as ingestin f nn steridal anti-inflammatry drugs (NSAIDs). Grades f recmmendatin: Grade C is directly based n: categry III evidence, r extraplated recmmendatin frm categry I r II evidence Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 33

34 authrs, date and cuntry Recmmendatins and gd practice pints f having cmmenced the swallwing prcess), an urgent referral shuld be made. Grade C Helicbacter pylri status shuld nt affect the decisin t refer fr suspected cancer. Grade C In patients withut dyspepsia, but with unexplained weight lss r irn deficiency anaemia, the pssibility f upper gastrintestinal cancer shuld be recgnised and an urgent referral fr further investigatin cnsidered. Grade C In patients with persistent vmiting and weight lss in the absence f dyspepsia, upper gastr-esphageal cancer shuld be cnsidered and, if apprpriate, an urgent referral shuld be made. Grade C An urgent referral shuld be made fr patients presenting with either: unexplained upper abdminal pain and weight lss, with r withut back pain, r an upper abdminal mass withut dyspepsia. Grade C In patients with bstructive jaundice an urgent referral shuld be made, depending n the patient s clinical state. An urgent ultrasund investigatin may be cnsidered if available. Grade C Cmments Grade D is directly based n: categry IV evidence, r extraplated recmmendatin frm categry I, II, r III evidence. Levels f evidence: Ia: Evidence frm systematic review r meta-analysis f randmised cntrlled trials Ib: Evidence frm at least ne randmised cntrlled trial IIa: Evidence frm at least ne welldesigned cntrlled study withut randmisatin IIb: Evidence frm at least ne welldesigned quasi-experimental study, such as a chrt study III: Evidence frm well-designed nnexperimental descriptive studies, casecntrl studies, r case series IV: Evidence frm expert cmmittee reprts, pinins and/r clinical experience f respected authrities. Risk factrs: In patients with unexplained wrsening f their dyspepsia, an urgent referral shuld be cnsidered if they have any f the fllwing knwn risk factrs: Barrett s esphagus knwn dysplasia, atrphic gastritis r intestinal metaplasia peptic ulcer surgery mre than 20 years ag. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 34

35 authrs, date and cuntry Recmmendatins and gd practice pints Grade C Investigatins: Patients being referred urgently fr endscpy shuld ideally be free frm acid suppressin medicatin, including prtn pump inhibitrs r H 2 receptr antagnists, fr a minimum f 2 weeks. Grade C In patients where the decisin t refer has been made, a full bld cunt may assist specialist assessment in the utpatient clinic. This shuld be carried ut in accrdance with lcal arrangements. Grade D All patients with new-nset dyspepsia shuld be cnsidered fr a full bld cunt in rder t detect irn deficiency anaemia. Grade D Cmments Suspected cancer in primary care: guidelines fr investigatins, referral and reducing ethnic disparities - New Zealand Guidelines Grup New Zealand Gastric and esphageal cancer Urgent referral (within 2 weeks) Recmmendatins: A persn f any age with dyspepsia shuld be referred urgently fr endscpy r t a specialist if they have any f the fllwing: gastrintestinal bleeding dysphagia prgressive unexplained weight lss persistent vmiting irn deficiency anaemia epigastric mass.* Grade C A persn aged 55 years r lder with unexplained and persistent recent-nset dyspepsia slely, shuld be referred urgently fr endscpy.* Grade C A persn with dysphagia (specifically, interference with Quality: 7 Recmmend: Yes, with mdificatins Grades f recmmendatin: All grades indicate the strength f the supprting evidence, rather than the imprtance f the recmmendatins. Grade C refers t recmmendatins supprted by internatinal expert pinin. Gd practice pints are develped, where n evidence is available, based n the pinin f the Guideline Develpment Team, r feedback frm cnsultatin within New Zealand. Evidence Tables - Scttish referral guidelines fr suspected cancer (August 2014) 35

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking

Public consultation on the NHMRC s draft revised Australian alcohol guidelines for low-risk drinking Public cnsultatin n the NHMRC s draft revised Australian alchl guidelines fr lw-risk drinking Recmmendatins frm The Cancer Cuncil Australia The Cancer Cuncil Australia is Australia s peak nn-gvernment

More information

BRCA1 and BRCA2 Mutations

BRCA1 and BRCA2 Mutations BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease

More information

Referral Criteria: Inflammation of the Spine Feb

Referral Criteria: Inflammation of the Spine Feb Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses

More information

ACRIN 6666 Screening Breast US Follow-up Assessment Form

ACRIN 6666 Screening Breast US Follow-up Assessment Form Screening Breast US Fllw-up Assessment Frm N. Instructins: The frm is cmpleted at 12, 24 and 36 mnths pst initial n study mammgraphy and ultrasund by the Radilgist r RA. Reprt all interim infrmatin related

More information

Prostatitis - chronic - Management

Prostatitis - chronic - Management Prstatitis - chrnic - Management Scenari: Diagnsis f chrnic prstatitis Hw shuld I diagnse chrnic prstatitis? Diagnse chrnic prstatitis if: The man has pain in the perineum r pelvic flr and lwer urinary

More information

WHAT IS HEAD AND NECK CANCER FACT SHEET

WHAT IS HEAD AND NECK CANCER FACT SHEET WHAT IS HEAD AND NECK CANCER FACT SHEET This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice

More information

Obesity/Morbid Obesity/BMI

Obesity/Morbid Obesity/BMI Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

US Public Health Service Clinical Practice Guidelines for PrEP

US Public Health Service Clinical Practice Guidelines for PrEP Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S

More information

Seeking and Appraising Evidence

Seeking and Appraising Evidence EWMA Educatinal Develpment Prgramme Curriculum Develpment Prject Educatin Mdule: Seeking and Appraising Evidence Latest review: August 2012 Educatin Mdule: Seeking and Appraising Evidence ABOUT THE EWMA

More information

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder? updated 2012 Relaxatin training Q 5: Is relaxatin training better (mre effective than/as safe as) than treatment as usual in adults with depressive episde/disrder? Backgrund The number f general health

More information

Significance of Chronic Kidney Disease in 2015

Significance of Chronic Kidney Disease in 2015 1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care

More information

EVIDENCE TABLES Table 1: Recommendations from United Kingdom (UK) and international referral guidelines for patients with suspected lung cancer

EVIDENCE TABLES Table 1: Recommendations from United Kingdom (UK) and international referral guidelines for patients with suspected lung cancer EVIDENCE TABLES Table 1: Recommendations from United Kingdom (UK) and international referral guidelines for patients with suspected lung cancer Title authors, date and country Lung cancer: the diagnosis

More information

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache Measure Descriptin All patients diagnsed with migraine headache r cervicgenic headache wh had a headache management

More information

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights. HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,

More information

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select

More information

Frequently Asked Questions: IS RT-Q-PCR Testing

Frequently Asked Questions: IS RT-Q-PCR Testing Questins 1. What is chrnic myelid leukemia (CML)? 2. Hw des smene knw if they have CML? 3. Hw is smene diagnsed with CML? Frequently Asked Questins: IS RT-Q-PCR Testing Answers CML is a cancer f the bld

More information

Kent and Medway Policy Recommendation and Guidance Committee Policy Recommendation

Kent and Medway Policy Recommendation and Guidance Committee Policy Recommendation Kent and Medway Plicy Recmmendatin and Guidance Cmmittee Plicy Recmmendatin Plicy: PR 2017-11: Surgery fr haemrrhids Issue date: July 2017 Review date: July 2020 The Kent and Medway Plicy Recmmendatin

More information

REFERRAL GUIDELINES Upper Gastro-Intestinal & Hepaticobilary

REFERRAL GUIDELINES Upper Gastro-Intestinal & Hepaticobilary REFERRAL GUIDELINES Upper Gastr-Intestinal & Hepaticbilary Referral Frm: The GP Referral Template is the preferred referral tl (previusly knwn as the Victrian Statewide Referral Frm) GP Referral Template

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

ACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.

ACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals. 27 March 2014 Prfessr Debra Picne Chief Executive Officer Australian Cmmissin n Safety and Quality in Health Care c/ Ms Jennifer Hill, Senir Prject Officer Level 5, 255 Elizabeth Street SYDNEY NSW 2000

More information

ITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child.

ITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child. Acute Immune Thrmbcytpenia Purpura (ITP) Backgrund Primary immune thrmbcytpenia (ITP) is an acquired immune mediated disrder characterised by islated thrmbcytpenia, defined as a peripheral bld platelet

More information

Ischemic heart disease (angina/chest pain)

Ischemic heart disease (angina/chest pain) Ischemic heart disease (angina/chest pain) External resurces Stable angina: management NICE guidelines [CG126] Updated :Aug 2016 https://www.nice.rg.uk/guidance/cg126 Chest pain f recent nset [CG95] Nvember

More information

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information Structured Assessment using Multiple Patient Scenaris (StAMPS) Exam Infrmatin 1. Preparing fr the StAMPS assessment prcess StAMPS is an assessment mdality that is designed t test higher rder functins in

More information

Safety of HPV vaccination: A FIGO STATEMENT

Safety of HPV vaccination: A FIGO STATEMENT FIGO Statement n HPV Vaccinatin Safety, August 2nd, 2013 Safety f HPV vaccinatin: A FIGO STATEMENT July, 2013 Human papillmavirus vaccines are used in many cuntries; glbally, mre than 175 millin dses have

More information

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic

More information

DRAFT Policy for the Management of Ear Wax

DRAFT Policy for the Management of Ear Wax Clinical Cmmissining Grup (CCG) Treatment Plicy NHS Birmingham and Slihull Clinical Cmmissining Grup NHS Sandwell and West Birmingham Clinical Cmmissining Grup DRAFT Plicy fr the Management f Ear Wax 1

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

Cancer in Primary Care

Cancer in Primary Care Reprt fr the Natinal Awareness and Early Diagnsis Initiative Cancer in Primary Care AN ANALYSIS OF SIGNIFICANT EVENT AUDITS (SEA) FOR CANCER DIAGNOSIS: 2008 2009 Mitchell E, Macled U, Rubin G July 2009

More information

2. How are screening and diagnostic mammograms different?

2. How are screening and diagnostic mammograms different? Mammgrams cmprises public dmain material frm the Natinal Cancer Institute at the Natinal Institutes f Health, an agency f the U.S. Department f Health and Human Services. Mammgrams Key Pints A mammgram

More information

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning Plicy Guidelines: Genetic Testing fr Carrier Screening and Reprductive Planning Cntents Overview... 1 Cverage guidelines... 2 General cverage guidelines... 2 Rutine carrier screening... 2 Carrier screening

More information

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review: Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign

More information

decreased when the man lies down. The varicocele cannot usually be palpated lying down.

decreased when the man lies down. The varicocele cannot usually be palpated lying down. Variccele - Management View full scenari Hw d I knw my patient has a variccele? The man may present with cncern abut scrtal swelling r scrtal pain, r a variccele may be an incidental finding n physical

More information

Human papillomavirus (HPV) refers to a group of more than 150 related viruses.

Human papillomavirus (HPV) refers to a group of more than 150 related viruses. HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between

More information

CDC Influenza Division Key Points MMWR Updates February 20, 2014

CDC Influenza Division Key Points MMWR Updates February 20, 2014 CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February

More information

WCPT awards programme 2015

WCPT awards programme 2015 WCPT awards prgramme 2015 The WCPT awards prgramme recgnises utstanding cntributins and leadership by individual physical therapists and grups t the prfessin and/r glbal health at an internatinal level.

More information

Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Chrnic Fatigue Syndrme (Als knwn as Myalgic encephalmyelitis/encephalmyelpathy) What is CFS/ME? CFS/ME cmprises a range f symptms that include fatigue, malaise, headaches, sleep disturbances, difficulties

More information

CDC Influenza Technical Key Points February 15, 2018

CDC Influenza Technical Key Points February 15, 2018 CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity

More information

Hospital Preparedness Checklist

Hospital Preparedness Checklist Hspital Preparedness Checklist http://pandemicflu.gv Preparedness Subject 1. Structure fr planning and decisin making An internal, multidisciplinary planning cmmittee fr influenza preparedness has been

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-6 (NQF 0034): Clrectal Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

A foot x-ray series is required only if there is pain in the midfoot zone and any one of the following:

A foot x-ray series is required only if there is pain in the midfoot zone and any one of the following: RADIOGRAPHY OF THE ANKLE AND FOOT (OTTAWA ANKLE RULES) Clinical Practice Guideline January 2007 This guideline has been adapted frm the Ottawa Ankle Rules develped by Dr. Ian Stiell et al. Dr. Stiell received

More information

Widening of funding restrictions for rituximab and eltrombopag

Widening of funding restrictions for rituximab and eltrombopag 20 February 2014 Widening f funding restrictins fr rituximab and eltrmbpag PHARMAC is pleased t annunce the apprval f prpsals t widen the restrictin n rituximab use in DHB hspitals and expand the funding

More information

Osteoporosis Fast Facts

Osteoporosis Fast Facts Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased

More information

EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL

EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL Cncussin awareness has increased significantly in recent years. The Natinal Cllegiate Athletic Assciatin (NCAA), Natinal Athletic Trainers Assciatin

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. The United States is currently experiencing a natinwide utbreak f entervirus D68 (EV-D68) assciated with severe

More information

2018 Medical Association Poster Symposium Guidelines

2018 Medical Association Poster Symposium Guidelines 2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April 13-14 at the

More information

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED

More information

Diabetes: HbA1c Poor Control (NQF 0059)

Diabetes: HbA1c Poor Control (NQF 0059) Diabetes: HbA1c Pr Cntrl (NQF 0059) EMeasure Name Diabetes: HbA1c Pr Cntrl EMeasure Id Pending Versin Number 1 Set Id Pending Available Date N infrmatin Measurement January 1, 20xx thrugh Perid December

More information

Related Policies None

Related Policies None Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER

More information

Alcohol & Substance Misuse Policy. St Mary s CE Academy Trading Company. Date: Spring 2017 Date of Next Review: Summer 2018

Alcohol & Substance Misuse Policy. St Mary s CE Academy Trading Company. Date: Spring 2017 Date of Next Review: Summer 2018 St Mary s CE Academy Trading Cmpany Alchl & Substance Misuse Plicy Date: Spring 2017 Date f Next Review: Summer 2018 Signed by: Family Supprt Crdinatr Signed by: Grup Manager Alchl and Substance Misuse

More information

Risk factors in health and disease

Risk factors in health and disease Risk factrs in health and disease Index 1 Intrductin 2 Types f risk factrs 2.1 Behaviural risk factrs 2.2 Psychlgical risk factrs 2.3 Demgraphic risk factrs 2.4 Envirnmental risk factrs 2.5 Genetic risk

More information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red. Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. Over the last several mnths, the United States has experienced a natinwide utbreak f entervirus D68 (EV- D68) assciated

More information

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 216 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS This briefing has been specifically prepared fr the Ministry f Health t prvide infrmatin frm this

More information

Adult Preventive Care Guidelines

Adult Preventive Care Guidelines Adult Preventive Care Guidelines Gundersen is yur partner fr better health. We want t wrk with yu t make sure that yu and yur family are as healthy as pssible. That can be accmplished best if we wrk tgether

More information

Background 1. Definition Fibroadenoma: Group of hyperplastic breast lobules composed of stromal and epithelial elements

Background 1. Definition Fibroadenoma: Group of hyperplastic breast lobules composed of stromal and epithelial elements Fibradenma Backgrund 1. Definitin Fibradenma: Grup f hyperplastic breast lbules cmpsed f strmal and epithelial elements Simple benign slid tumrs with glandular and fibrus tissue Cmplex Scleringadensis

More information

Imaging tests allow the cancer care team to check for cancer and other problems inside the body.

Imaging tests allow the cancer care team to check for cancer and other problems inside the body. IMAGING TESTS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between yu

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQ s) Fr PA Health & Wellness Prviders Questin GENERAL Why is PA Health & Wellness implementing a Medical Specialty Slutins Prgram? Answer

More information

Health Science Ch. 16 Cancer Lecture Outline

Health Science Ch. 16 Cancer Lecture Outline Cancer Leading cause f disease-related death amng peple under age 75 Secnd leading cause f death Evidence supprts that mst cancers culd be prevented by simple lifestyle changes Tbacc is respnsible fr abut

More information

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent

More information

Cardiac Rehabilitation Services

Cardiac Rehabilitation Services Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin

More information

The principles of evidence-based medicine

The principles of evidence-based medicine The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t

More information

Neurological outcome from conservative or surgical treatment of cervical spinal cord injured patients

Neurological outcome from conservative or surgical treatment of cervical spinal cord injured patients 1993 nternatinal Medical Sciety f Paraplegia eurlgical utcme frm cnservative r surgical treatment f cervical spinal crd injured patients J E Kiwerski Spinal Department f Metrplitan Rehabilitatin Centre,

More information

Completing the NPA online Patient Safety Incident Report form: 2016

Completing the NPA online Patient Safety Incident Report form: 2016 Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject

More information

OTHER AND UNSPECIFIED DISORDERS

OTHER AND UNSPECIFIED DISORDERS OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

Urinary tract infection (lower) - women - Management

Urinary tract infection (lower) - women - Management Urinary tract infectin (lwer) - wmen - Management Scenari: Cystitis in wmen wh are nt pregnant Hw shuld I manage a wman with suspected cystitis? Cnvey a psitive apprach and reassure the wman that cystitis

More information

Immunisation and Disease Prevention Policy

Immunisation and Disease Prevention Policy Immunisatin and Disease Preventin Plicy Quality Area 2: Children s Health and Safety 2.1 Each child s health is prmted 2.1.4 Steps are taken t cntrl the spread f infectius diseases and t manage injuries

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Luisiana Healthcare Cnnectins Prviders Questin GENERAL Why did Luisiana Healthcare Cnnectins implement a Medical Prgram? Answer

More information

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE Vaccine Infrmatin Statement: PNEUMOCOCCAL CONJUGATE VACCINE Many Vaccine Infrmatin Statements are available in Spanish and ther languages. See www.immunize.rg/vis. Hjas de Infrmacián Sbre Vacunas están

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is

More information

Lyme Disease Surveillance in North Carolina

Lyme Disease Surveillance in North Carolina Lyme Disease Surveillance in Nrth Carlina 2008-2014 Carl Williams DVM Megan Sanza MPH Cmmunicable Disease Branch Divisin f Nrth Carlina Public Health Lyme Disease Surveillance in Nrth Carlina 2008-2014

More information

Chapter 6: Impact Indicators

Chapter 6: Impact Indicators Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the

More information

Managing the Symptoms of Stroke

Managing the Symptoms of Stroke Unit 26: Recgnising and Managing the Symptms f Strke Unit reference number: F/616/7312 Level: 2 Unit type: Optinal Credit value: 3 Guided learning hurs: 28 Unit summary A strke can be a life-threatening

More information

Improving Surveillance and Monitoring of Self-harm in Irish Prisons

Improving Surveillance and Monitoring of Self-harm in Irish Prisons HSE Mental Health Divisin Stewart s Hspital, Palmerstwn, Dublin 20 Tel: 01 6201670 Email: inf@nsp.ie www.nsp.ie Imprving Surveillance and Mnitring f Self-harm in Irish Prisns Prject Scpe Dcument 8 th June

More information

Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations

Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations Implementatin f G6PD testing and radical cure in P. vivax endemic cuntries: cnsideratins Malaria Plicy Advisry Cmmittee Geneva, Switzerland 16-18 September 2015 1 WHO Guidelines n Radical Cure WHO guidelines

More information

BP Thresholds for Medical Review

BP Thresholds for Medical Review BP Threshlds fr Medical Review Wmen presents t GP pstnatally with high bld pressure r referred t GP by midwife GP t review patient n the same day if BP>150/100. If BP (dne by midwife) persistently 140-149/90-99,

More information

Specifically, on page 12 of the current evicore draft, we find the statement:

Specifically, on page 12 of the current evicore draft, we find the statement: Octber 23, 2016 evicre Healthcare Attn: Dr Greg Allen 400 Buckwalter Place Bulevard Blufftn, SC 29910 RE: evicre Draft Onclgy Imaging Guidelines, v 19.0 Gentlepersns: Prstate Cancer Internatinal is a nt-fr-prfit

More information

Cancer Association of South Africa (CANSA)

Cancer Association of South Africa (CANSA) Cancer Assciatin f Suth Africa (CANSA) Fact Sheet and Psitin Statement n Cannabis in Suth Africa Intrductin Cannabis is a drug that cmes frm Indian hemp plants such as Cannabis sativa and Cannabis indica.

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS) Questin GENERAL Why did MHS implement a Medical Specialty Slutins Prgram? Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Managed Health Services (MHS) Answer Effective Nvember

More information

Solid Organ Transplant Benefits to Change for Texas Medicaid

Solid Organ Transplant Benefits to Change for Texas Medicaid Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a

More information

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline) Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting

More information

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU

More information

Independent Charitable Patient Assistance Program (IPAP) Code of Ethics

Independent Charitable Patient Assistance Program (IPAP) Code of Ethics Independent Charitable Patient Assistance Prgram (IPAP) Cde f Ethics Independent charitable patient assistance prgrams (IPAPs) fcus n the needs f patients wh are insured, meet certain financial limitatin

More information

Consensus Recommendations for the Management of Chronic Lymphocytic Leukemia: Primary Care Guideline

Consensus Recommendations for the Management of Chronic Lymphocytic Leukemia: Primary Care Guideline Practice Guideline: Clinical Guide Cnsensus Recmmendatins fr the Management f Chrnic Lymphcytic Leukemia: Primary Care Guideline CCMB Practice Guideline Clinical Guide Develped by: Lymphprliferative Disrders

More information

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH Aurra Health Care s Research Subject Prtectin Prgram (RSPP) This guidance dcument will utline the prper prcedures fr btaining and dcumenting

More information

Guideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations

Guideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations Natinal Imaging Assciates, Inc. Clinical guidelines PARAVERTEBRAL FACET JOINT INJECTIONS OR BLOCKS CPT Cdes: Cervical Thracic Regin: 64490 (+ 64491, +64492), 0213T (+0214T, +0215T) Lumbar Sacral Regin:

More information

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by ESTIMATION PROCEDURES USED TO PRODUCE WEEKLY FLU STATISTICS FROM THE HEALTH INTERVIEW SURVEY James T. Massey, Gail S. Pe, Walt R. Simmns Natinal Center fr Health Statistics. INTRODUCTION In April 97, the

More information

The data refer to persons aged between 15 and 54.

The data refer to persons aged between 15 and 54. Drug-related hspital stays in Australia 1993-2005 Prepared by Amanda Rxburgh and Luisa Degenhardt, Natinal Drug and Alchl Research Centre Funded by the Australian Gvernment Department f Health and Ageing

More information

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS 1 SECTION 1 INTRODUCTION: EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS The Nature Of Assessment The Definitin Of Assessment The Difference Between Testing, Measurement And Evaluatin Characteristics

More information

Injury, Incident & Illness Procedure

Injury, Incident & Illness Procedure Injury, Incident & Illness Prcedure Injury / Incident Includes any child, adult, r emplyee injured n site. A first aid kit will be available at all times. It will be maintained in accrdance with criterin

More information

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009 CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral

More information

Pain relief after surgery

Pain relief after surgery Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read

More information

CDC Influenza Division Key Points November 7, 2014

CDC Influenza Division Key Points November 7, 2014 In this dcument: Summary Key Messages FluView Activity Update LAIV Effectiveness and Vaccinatin f Children H3N2 Match and Vaccinatin Vaccine Supply Summary Key Messages This week s FluView reprt indicates

More information

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre

More information

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results

More information

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will:

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will: Nutritin Care Prcess Mdel Tutrials Nutritin Care Prcess and Terminlgy Cmmittee Academy f Nutritin and Dietetics Nutritin Care Prcess Terminlgy 2015 Editin Nutritin Mnitring & Evaluatin: Overview & Definitin

More information

Prevention Checklist for Men

Prevention Checklist for Men Page 1 f 5 Preventin Checklist fr Men A lt f prgress has been made in cancer research, but we still dn t understand exactly what causes mst cancers. We d knw that many factrs put us at higher risk fr different

More information